DGX

Quest Diagnostics

DGX · Salud · Next earnings: 22 Oct 2026 · Before the open · Q3 2026

Relevance 38/100 · Minor

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

Sector Healthcare · Diagnostics & Research
Website https://www.questdiagnostics.com

What the market expects

ConsensusPrior-year EPS

EPS2.872.60

Revenue3,049,907,440—

14 analysts

How expectations have moved

Expectations: High

Expectativas elevadas: la acción acumula +11% en 90 días y cotiza a un 7% de su máximo de 52 semanas. Superar el consenso no garantiza una subida — el mercado puede tener ya descontado un buen resultado.

Stock, 90 days: +11.3%

Prior behaviour

Average absolute move: 5.9%
Largest move: 8.6%
releases with a move larger than 5%: 50%
beat the EPS consensus in: 4 of the last 4

Quarter Date 1-session move Surprise EPS

Jun 2026 23 Jul 2026 +8.6% +11.0%

Mar 2026 21 Apr 2026 +4.5% +5.5%

Dec 2025 10 Feb 2026 +7.4% +3.0%

Sep 2025 21 Oct 2025 -3.0% +3.6%

Historical moves describe typical magnitude, not a future direction.

Expected move

±5.9% (historical)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price: 230.81
30 days: -2.0%
90 days: +11.3%
Distance to 52-week high: -7.2%
Market cap: 25,475,274,800

Metrics to watch

El trimestre anterior batió el consenso de BPA un 11%.
Ventas del fármaco o producto principal
Guidance de ingresos anual
Avances de pipeline / ensayos clínicos mencionados
Margen operativo
BPA e ingresos frente al consenso (sorpresa)
Cambio en el guidance respecto al trimestre anterior
Reacción del mercado frente al movimiento histórico y al implícito

Relevance breakdown

market_cap: 7.7
analyst_coverage: 5.6
estimate_revisions: 0.3
recent_price_move: 0.8
historical_earnings_vol: 8.8
sector_importance: 4.0
recent_news_coverage: 7.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.